Clinical trial
Vascular Pathophysiology in Obstructive Sleep Apnea
NCT00214084 · University of Wisconsin, Madison, Other · Withdrawn
Key facts
| NCT number | NCT00214084 |
|---|---|
| Title | Vascular Pathophysiology in Obstructive Sleep Apnea |
| Official title | Influence of Xanthine Oxidase Inhibition on Vascular Function in Obstructive Sleep Apnea |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Obstructive Sleep Apnea |
| Intervention type | Drug |
| Interventions | Allopurinol |
| Enrollment | 0 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 8, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: